Clinical Trial

Assessment of Artificial Intelligence Algorithms for ROTEM

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
The study was stopped because it was considered unlikely that the required number of patients could be prospectively recruited across the participating study centers.
Summary
The goal of this observational validation study is to evaluate whether artificial intelligence (AI) models can accurately interpret ROTEM (Rotational Thromboelastometry) data and provide appropriate treatment recommendations in adult patients undergoing elective cardiac or liver transplantation surgery. The main questions it aims to answer are: Can AI models (e.g., ChatGPT and Gemini ) accurately determine whether treatment is indicated based on ROTEM parameters? Can AI models correctly identify the type of coagulopathy (e.g., fibrinogen deficiency, platelet dysfunction)? Are the treatment recommendations from AI models concordant with expert clinical consensus? Researchers will compare the decisions made by AI models to a gold standard expert panel to see if AI models can match or approximate expert-level decision-making in interpreting ROTEM outputs. Participants will: Undergo elective cardiac or liver transplant surgery. Have standard ROTEM tests performed intraoperatively. Have their anonymized ROTEM data reviewed independently by: A panel of 3 clinical experts. AI models (ChatGPT and Gemini) using standardized prompts and ROTEM interpretation guidelines.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-06-21; most recent amendment 2026-06-30.
Status change: Recruiting → Withdrawn 2026-06-30
Status change: Not Yet Recruiting → Recruiting 2025-07-15
Trial Details
NCT Number NCT07043556
Lead Sponsor Ondokuz Mayıs University
Conditions Coagulopathy
Start Date 2025-07-01
Primary Completion 2026-01-05 (estimated)
Study Completion 2026-03-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-02